PARALLAX HEALTH SCIENCES, INC. Deferred Compensation Equity
PARALLAX HEALTH SCIENCES, INC. had Deferred Compensation Equity of $1.10 million as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:DeferredCompensationEquity · last filed 2019-12-13
- 2019-03-31: Deferred Compensation Equity $1.10M.
- 2018-12-31: Deferred Compensation Equity $1.15M.
- 2018-09-30: Deferred Compensation Equity $1.11M.
- 2018-06-30: Deferred Compensation Equity $1.67M.
| Period end | Deferred Compensation Equity |
|---|---|
| 2019-03-31 | $1.10M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.15M 10-K/A · filed 2019-12-13 |
| 2018-09-30 | $1.11M 10-Q · filed 2019-03-11 |
| 2018-06-30 | $1.67M 10-Q · filed 2018-09-28 |
| 2018-03-31 | $1.77M 10-Q · filed 2018-09-20 |
| 2017-12-31 | $1.81M 10-K/A · filed 2019-12-13 |
| 2017-09-30 | $1.95M 10-Q · filed 2018-08-31 |
| 2017-06-30 | $117.85K 10-Q · filed 2018-08-31 |
| 2016-12-31 | $0.00 10-K · filed 2018-09-10 |